|
Volumn 18 Suppl 2, Issue , 2003, Pages
|
Anaemia management prior to dialysis: cardiovascular and cost-benefit observations.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ERYTHROPOIETIN;
RECOMBINANT ERYTHROPOIETIN;
ANEMIA;
CARDIOVASCULAR DISEASE;
CHRONIC KIDNEY FAILURE;
COMORBIDITY;
COST BENEFIT ANALYSIS;
ECONOMICS;
HOSPITALIZATION;
HUMAN;
RENAL REPLACEMENT THERAPY;
RETROSPECTIVE STUDY;
REVIEW;
ANEMIA;
CARDIOVASCULAR DISEASES;
COMORBIDITY;
COST-BENEFIT ANALYSIS;
ERYTHROPOIETIN;
ERYTHROPOIETIN, RECOMBINANT;
HOSPITALIZATION;
HUMANS;
KIDNEY FAILURE, CHRONIC;
RENAL DIALYSIS;
RETROSPECTIVE STUDIES;
|
EID: 0042708598
PISSN: 09310509
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (89)
|
References (25)
|